Members of the European Biotechnology Network will benefit from a special discount. Please contact office@european-biotechnology.net to receive a promo code. Discounts always apply on the “regular fee” except during the “late registration” period. Discount cannot be combined with any other offer.

Step into the heart of biomanufacturing’s next chapter at the Keynotion Global Bioprocessing Summit & Exhibition 2025, a gathering built for those who do not simply follow innovation but lead it.

Addressing a key bottleneck in analytics: Capsid quantification remains a challenge in AAV

vector development. Manual ELISAs are time-consuming and variable, while many

automated systems are built for clinical settings — limiting flexibility and increasing costs.

Applied across development pipelines: The Clinical Biotechnology Centre (NHS Blood

and Transplant, UK Gene Therapy Innovation Hubs) has integrated a RED (Redox

Electrochemical Detection)-based platform (Amperia”™) within its AAV vector workflow

spanning early R&D through to larger-scale production.

Enabling adaptable, on-demand decision making: The system supports assay switching

across serotypes and allows in-process titre checks, helping teams stay agile

and responsive across multiple projects and stages.

Improving efficiency without compromising performance: Comparisons with automated

ELISAs demonstrate comparable accuracy, while offering significant gains in turnaround

time, workflow simplicity, and cost-effectiveness. Amperia™ is now actively supporting

vector quantification within this ongoing development programme.

more infomation here:

https://key-notion.com/global-bioprocessing-summit-exhibition-2025/